De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus | Ahmed Hosni Kamel Abdelmaksoud

De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus

Citation:: Abdelaziz, A. O., M. M. Nabi, A. H. Abdelmaksoud, H. I. Shoushaa, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology & Hepatology, vol. 30, issue 1, pp. 39–43, 2018.